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Abstract 
Background: Transitioning a patient from the hospital to home is an area of vulnerability for patients with Chronic Obstructive 
Pulmonary Disease (COPD).  Patients with COPD frequently readmit as they often do not understand their disease state, medications 
or when to seek medical attention. Objectives: The objective of this study is to determine the impact that pharmacist-led education 
has on a patient’s understanding of their disease state by assessing the results of the Lung Information Needs Questionnaire (LINQ). 
Methods:  This study uses a quasi-experimental design to formally assess pharmacist-led education provided to patients with COPD 
using the LINQ. The LINQ was used to assess knowledge of the disease state and medications before and after receiving education on 
disease state management, smoking cessation and proper medication use.   Results: A total of 17 patients completed the LINQ. The 
survey results showed a statistically significant improvement in patient understanding in 4 of the 6 targeted areas. Conclusion: Results 
from the formal assessment using the LINQ suggest that pharmacist-lead education for COPD patients is beneficial and reliable. This 
study presents a continued need for patient education and research in this high-risk patient population. 
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Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a progressive 
respiratory illness that contributes considerably to morbidity 
and mortality as the third leading cause of death in the United 
States. As the disease progresses, patients will experience 
increased dyspnea, sputum production, coughing, inability to 
perform activities of daily living, and an overall decline in 
mental and physical wellbeing. [1]  
 
Transitioning a patient home after discharge has historically 
been an area of vulnerability for patients with Chronic 
Obstructive Pulmonary Disease (COPD).[1] Studies have shown 
that patients with COPD often do not understand their disease 
state, how to properly use their medications or when to seek 
treatment during an exacerbation.[2-4] Qualitative research 
has described the need for pharmacist integration into 
transitions of care (TOC) teams to prevent medication-related 
problems and identify components that contribute to 30-day 
readmissions. However, more studies are needed to determine 
the correlation of pharmacist involvement on TOC teams and 
reduction in readmission rates. [5, 6] 
 
Baptist Memorial Hospital – North Mississippi (BMH-NM), a 
217-bed community hospital in Northeast Mississippi, 
introduced a pharmacist-led COPD transitions service in 
December 2017. The pharmacist-led COPD service protocol 
provided physicians with the option to consult pharmacy to 
perform disease state management services for patients  
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admitted with a COPD exacerbation.  Following the initiation of 
the service, the Lung Information Needs Questionnaire (LINQ) 
was identified as a useful instrument to assess the benefit of 
the education pharmacists were providing. 
 
 The LINQ is an instrument used to assess the education needs 
of patients with COPD. It consists of 16 items and 6 domains. [7, 
8] The six domains each have subscale scores: disease state 
knowledge (0-4), medication knowledge (0-5), self-
management ability (0-6), smoking status (0-3), knowledge of 
exercise requirements (0-5) as well as knowledge of an 
appropriate diet (0-2). Higher scores in each domain indicate a 
greater need for education in that area per respondent. The 
total summed score has a range from 0 to 25, with a score of 0 
indicating complete understanding, and a score of 25 indicating 
the need for education in all areas. [7-9] 
 
Upon consultation, a pharmacist would provide thorough 
disease state education and medication management in 
accordance with the pharmacist-led COPD service protocol. 
Additionally, in order to assess the benefit and reliability of the 
education being provided by pharmacists, the Lung Information 
Needs Questionnaire (LINQ) would be given to a group of 
patients prior to and after education. 
 
The primary objective of this study was to determine the impact 
that pharmacist-led education has on a patient’s understanding 
of their disease state by assessing the results of the Lung 
Information Needs Questionnaire prior to and following patient 
education sessions. 
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Methods 
This study was approved by the Institutional Review Board of 
Baptist Memorial Healthcare Corporation (BMHCC) to be 
conducted at BMH-NM. Patients included in the study were 
over the age of 18 years, were admitted with a COPD 
exacerbation and for whom pharmacy was consulted for COPD 
education and management.  Patients were excluded if they did 
not speak English or were unable to understand the contents of 
the survey.  
 
The pharmacist-led COPD transitions service began in 
December 2017 with pharmacists completing consultations per 
standard protocol. The pharmacy department would be 
consulted by a physician to initiate the COPD service. After 
consultation, the pharmacist would perform disease state and 
smoking cessation education during the initial visit. Then the 
pharmacist would confer with the physician to determine the 
patient’s needs inpatient and upon discharge. Finally, prior to 
discharge, the pharmacist would return to educate on proper 
inhaler technique, ensure optimization of home COPD 
medications, and answer all patient questions.  
 
IRB approval for the administration of the LINQ survey and 
chart review was obtained in February of 2018 and all patients 
seen by the pharmacy department from that point forward 
were invited to participate in the survey. With each consult 
initiation, the patient was given the opportunity to receive 
education with or without completing the LINQ.  If the patient 
opted to participate in the survey, it was administered either 
orally by the pharmacist or completed as a written assessment 
by the patient.  The baseline data collected included patient 
name, age, gender, smoking history, home/inpatient 
medication regimen and primary care provider and/or 
pulmonologist.  
 
After completion of the survey, the pharmacist performed 
disease state education, smoking cessation education, 
demonstration of inhaler technique, assessment and 
optimization of home and hospital COPD treatment regimens 
and medication procurement (if financial need was evident). 
Disease state and smoking cessation education and therapy 
optimization most often occurred during the initial visit 
immediately after completion of the LINQ, while demonstration 
of inhaler technique and acquisition of medication transpired 
closer to the patient’s discharge. The pharmacist performed a 
follow-up call for LINQ participants 48-72 hours after discharge. 
During the follow-up call, the pharmacist repeated the 
questions from the LINQ survey and the responses were 
compared to the pre-education responses.  The pharmacist 
also verified that the patient was able to acquire all discharge 
medications and was aware of their follow-up visit with their 
provider.  Finally, the pharmacist reviewed the patient’s 
wellbeing and ability to self-manage his or her disease state, 
including key points regarding when to seek help in an 
exacerbation. 
 
Results 
A total of 18 patients were available and agreed to participate 
in the LINQ. One of the 18 surveyed patients was not able to 
comprehend the contents of the questionnaire and was 
excluded from the LINQ analysis. Thus, the analysis for the LINQ 
was based on 17 patients (female = 10; 59%). The average age 
was 73 years (range= 51-89 years). 
 
The majority of LINQ participants (88%) were either smokers or 
former smokers, and all patients were determined to have 
severe COPD (severe COPD was categorized as any patient who 
required oxygen, had documented spirometry < 50%, or had 
greater than 2 hospital admissions for COPD in one year). Only 
35% of participants had been seen by a pulmonologist at any 
point, during a hospitalization or as an outpatient, and all 
participants were either Medicaid, Medicare or both 
Medicaid/Medicare patients. Characteristics for patients who 
completed both pre- and post-education LINQ surveys are 
shown in Table I. 
 
 
 
 
 
Table II presents information gathered about participants’ 
medication use upon admission and at discharge. The majority 
of patients (88%, n= 14) had identified medication            
problems (unaffordability, inappropriate medications,               
and noncompliance) upon admission. Pharmacists 
provided recommendations to physicians where appropriate 
(n=11), and 82% of these recommendations were accepted. Of 
the 17 patients surveyed, 2 (11.8%) patients were readmitted, 
one with a non – COPD related problem. 
 
Table I: Patient Characteristics for Survey Respondents (n = 17) 
Gender 59 % Female  (n = 10) 
41% Male (n = 7) 
Smoking Status 53% Former smoker  (n= 9) 
35% Current smoker (n = 6) 
12% Never smoker (n = 2) 
COPD stage (mild, moderate, 
severe) 
100% severe (n=17) 
Admission History in one year  47% had 2-3 admissions (n= 8) 
53% had > 3 admissions (n=9) 
Age of Diagnosis 24% 50-64 years (n= 4) 
47% 64-74 years (n= 8) 
29% >74 years (n= 5) 
Pulmonologist/PCP  35% had pulmonologist (n = 6) 
82% had PCP (n= 11) 
Insurance Status  53% Medicaid/Medicare (n = 9) 
41% Medicare alone (n = 7) 
6% Medicaid  alone (n = 1) 
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Table III depicts information on the outcomes of the LINQ; all 
comparisons are documented here. A Wilcoxon signed rank test 
was used to compare LINQ scores prior to education (pretest) 
and after discharge (posttest). Baseline total and individual 
domain scores were consistently higher in all participants with 
post-education scores being significantly improved across all 
domains, with the exception of diet and smoking habits. The 
medication education domain improved the most (p = 0.002), 
followed by self-management (p = 0.002).  Baseline scores for 
self-management were the highest among the 6 domains, 
meaning that patients often reported that they had not been 
told when to call an ambulance versus when to self-treat or 
seek attention from their primary care physician. After 
education by a pharmacist, this figure significantly improved. 
 
Medication management was the area of most improvement. 
Prior to institutional pharmacist-led education, many patients 
stated they had never been instructed on how to properly use 
their inhalers or why they were a necessity. This area also 
showed a statistically significant change after education and 
inhaler technique was provided (p = 0.002). Each consult 
involving the LINQ was recorded for time, and pharmacist 
intervention took an average of 30 minutes (range of 10 – 90 
minutes) with each consult (LINQ, education, and medication 
management) during this pilot period. 
 
Table III: LINQ Results Using a Paired T-test (n = 17) 
Study Parameter Mean 
Pre-Test 
(n=17) 
Mean 
Post 
Test 
(n=17) 
P-value 
(alpha = 
0.05) 
(n=17) 
Total LINQ score (0-25*) 12 (5-17) 4.77 
(0-15) 
<0.001 
Disease State Education (0-4*) 2.11 0.94 0.002 
Medication Education (0-5*) 2.11 0.764 0.002 
Self-management Education (0-6*) 3.82 1.29 0.002 
Exercise (0-5*) 2.88 1.29 0.003 
Diet (0-2*) 0.71 0.35 0.063 
*Higher numbers indicate a greater need for education.  
 
Discussion 
The results associated with pharmacist intervention suggest a 
trend toward positive outcomes and were documented by the 
LINQ survey results (see Table III). 
 
The LINQ survey detected areas of information needs and 
allowed pharmacists to provide targeted education to patients 
in our population. All 6 domain scores improved, with 4 
domains being statistically significant. The smoking domain was 
a baseline measurement and therefore did not qualify for 
statistical evaluation. Diet was also an area of least impact as 
patients expressed awareness of diet needs, but lacked 
motivation for change. 
 
This study revealed areas of weakness in standard education 
provided to patients with COPD who have frequent 
readmissions. Medication education was the most well 
received/appreciated education provided by pharmacists as 
was commonly voiced by patients at follow-up. Self-
management areas were most improved as patients were given 
a documented action plan for how to appropriately manage an 
acute exacerbation. While education was essential in improving 
patient outcomes, pharmacist intervention in ensuring 
discharge medications included both rescue and maintenance 
inhalers was impactful and accepted by physicians 82% of the 
time.  
 
There were a number of limitations observed during this study 
period. One of the most significant challenges faced during this 
pilot was the lack of additional staffing. All participants were 
seen and followed by one pharmacist who incorporated the 
service into her daily workflow. This created difficulty with 
prioritization of patients and the ability to include more 
patients into the study. All readmissions may not have been 
captured, as data were only available to be collected on those 
who were re-hospitalized at BMHCC affiliates.  
 
IRB approval for the incorporation of the LINQ was not obtained 
until February of 2018; therefore, only 17 patients were 
included in the study. The information from the LINQ portion of 
the study was presented at a conference, all data was to be 
included by April of 2018, which determined the stop date for 
administering the LINQ to patients. The LINQ was very time 
consuming and proved to be an unlikely addition to regular 
practice in an inpatient setting. However, the information 
collected on this small number of patients gave us great insight 
into the typical education needs of our patient population. The 
results also suggest that the education provided by a 
pharmacist was well received and appeared to have a useful 
and significant impact on patient understanding of their disease 
state and management. 
 
The exclusion criteria of determining a patient’s ability to 
understand was decided by the researcher who had direct 
contact with the patients. Patients were deemed “unable to 
understand” if they were asked a question and did not give a 
Table II: Population Data Identifying Medication Use (n=17) 
Medication Problems 
Identified  
88% med problems 
• 20% unaffordability 
• 67% inappropriate meds 
• 40% noncompliance 
Recommendation 
Accepted 
82% of prescribers accepted 
recommendation from pharmacist  
Discharge meds 
prescribed at discharge  
88% of patients given a prescription at 
discharge 
Readmitted within 30 
days  
2 readmissions (11.76%) 
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formed answer, did not answer at all, or regularly stated “I don’t 
know”. Therefore, this mode of patient exclusion could have 
introduced selection bias. A potential confounder on 30-day 
readmissions in this study was the involvement of a 
pulmonologist in some patients. While neither of the 2 readmits 
in this study were treated by pulmonology, it is difficult to 
conclude that pulmonologist involvement had a direct 
relationship in readmission status.   
 
Time required per consult, lack of staff participation, and 
transitioning control of this service to a new staff member all 
contributed to the lack of data collected beyond April of 2018.  
This pilot study was originally a resident project that continues 
to be improved at this facility to incorporate all staff. The data 
showed positive trends for justification of this service and 
therefore remains in place at this facility. Improvements 
continue to be made to this pharmacy service for maximum 
benefit within a more manageable time commitment.  
 
Conclusion 
In spite of the limitations of this study, the results from the LINQ 
data showed a clear positive trend of patient improvement in 
disease state and medication understanding after a pharmacist 
provided education and medication recommendations. As time 
and staffing was a problem identified in this pilot, changes are 
being made to ensure a streamlined approach to providing this 
service using all clinical and resident pharmacy staff at this 
institution. 
 
Use of the LINQ allowed for identification of specific areas of 
education need, thus allowing for a more streamlined approach 
to patient education among all patients pharmacy was 
consulted to manage in this study and for future patients. 
Pharmacist involvement with patient care transitions using 
targeted education techniques appeared to improve patient 
understanding and demonstrated trends toward decreased 30-
day readmission rates. This pilot study showed a need for 
continued research in order to adjust for seasonal readmission 
confounders, as well as expand the service to incorporate all 
pharmacy team members. [10-12] 
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